News
| 2 min read
The companies' TRAMmoniTRR Study will screen TTR-positive participants to determine if they have hereditary transthyretin-related amyloidosis
| 2 min read
Friends of Cancer Research unites industry, academia and regulatory partners in an effort to realize the potential of homologous recombination deficiency in cancer prognosis
| 2 min read
Researchers have discovered that SIGLEC12 contains several features unique to humans
| 3 min read
PhaseBio doses the first patients in Canada with its antiplatelet activity reversal therapy
| 3 min read
Pfizer and BioNTech have achieved the first authorization for a vaccine against COVID-19
| 3 min read
Valneva and Pfizer collaboration expands pediatric development for VLA15 vaccine
| 2 min read
Twirla is reportedly the first contraceptive patch to combine levonorgestrel and ethinyl estradiol
| 2 min read
Black and Hispanic populations’ heightened risk of exposure and transmission is primary factor of impact
| 2 min read
Transcriptome sequencing of patients with liver disease reveals gene expression changes that could help to track disease severity and progression
| 2 min read
The partners' work will focus on biomarker analysis to support clinical development of RGLS4326
| 2 min read
Horizon grants Sanyou two commercial licenses to its CHOSOURCE platform
| 2 min read
Catalyst Biosciences gains FDA Fast Track designation for subcutaneous MarzAA for the treatment of Hemophilia
